Fig. 5From: Ocular kinetics and safety of intravitreally injected angiotensin converting enzyme inhibitor lisinoprilThe study evaluated the retina for any possible toxicity for consecutive two vitreous half-life of lisinopril as calculated from the pharmacokinetic studies. The fundus photographs represent the fundus images of the injected eye at baseline, 24, 48, 72 and 168 hBack to article page